Gufic Biosciences stock rises~2% after application to NCLT for amalgamation of its arm
Gufic Lifesciences and Hetero have agreed to manufacture and supply Remdesivir Lyophilised Powder for injection indicated for emergency use in Covid-19 patients.
from India Infoline News Service https://ift.tt/3agDOLC
No comments:
Post a Comment